MTM Patient Assessment & Care Planning 5

Question 1

A patient taking lithium reports increased thirst, frequent urination, and hand tremors. During assessment, the pharmacist notes a lithium level of 1.6 mEq/L. What is the most appropriate care plan action?

Accepted Answer

Classify this as an adverse drug reaction due to toxicity and recommend urgent prescriber contact

Answer

A lithium level of 1.6 mEq/L exceeds the therapeutic range of 0.6–1.2 mEq/L, and toxicity symptoms confirm an adverse drug reaction requiring urgent intervention.

Question 2

When gathering a medication history during patient assessment, which source provides the most complete and accurate picture of current medications?

Accepted Answer

A brown bag review combined with pharmacy records and patient interview

Answer

A brown bag review combined with pharmacy records and a thorough patient interview captures prescription, OTC, and herbal medications across all providers.

Question 3

An MTM patient taking warfarin reports she started taking St. John's Wort for low mood. What drug therapy problem does this represent?

Accepted Answer

Adverse drug reaction due to a drug-herb interaction reducing warfarin efficacy

Answer

St. John's Wort induces CYP2C9 and P-glycoprotein, reducing warfarin levels and increasing thromboembolic risk, representing a clinically significant drug-herb interaction.

Question 4

In the Pharmacists' Patient Care Process (PPCP), which step directly follows 'Collect'?

Accepted Answer

Assess

Answer

The PPCP sequence is Collect → Assess → Plan → Implement → Follow-up and Monitor, making Assess the step that directly follows data collection.

Question 5

A newly diagnosed hypertensive patient refuses to start amlodipine due to fear of side effects. How should the pharmacist address this in the care plan?

Accepted Answer

Explore the patient's concerns using motivational interviewing, provide education, and document the barrier

Answer

Patient-centered care requires exploring concerns, providing accurate information, and documenting barriers to treatment as part of the collaborative care plan.

(MTM) Medication Therapy Management Board Certification Practice Test

(MTM) Medication Therapy Management Board Certification Practice Test

MTM Patient Assessment & Care Planning 5